Metraipolis › archive › dc_e46d88fb6dcf

Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca… — Europe PMC PMID:41285507

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41285507
DOI
10.1136/bmjopen-2025-105790
License (as archived)
solo-consultazione
Archived
2026-11-08T08:05:17.686Z
SHA-256 of the archived text
4b64e6073d212167aa62e43bf14c67b57040c6cfba6e9e3dcf5dba3c97ecafb5
Stable URL of this page
https://metraipolis.com/documento/dc_e46d88fb6dcf

How to cite

Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca… — Europe PMC PMID:41285507 — Europe PMC (en), https://europepmc.org/article/MED/41285507 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e46d88fb6dcf (Metraipolis archive dc_e46d88fb6dcf, sha256 4b64e6073d212167aa62e43bf14c67b57040c6cfba6e9e3dcf5dba3c97ecafb5)
BibTeX
@misc{dce46d88fb6dcf,
  title = {Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca… — Europe PMC PMID:41285507},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41285507},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e46d88fb6dcf; sha256 4b64e6073d212167aa62e43bf14c67b57040c6cfba6e9e3dcf5dba3c97ecafb5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41285507. Agents can read the archived copy with the MCP tool read_document.